is oral glp 1 fda approved Novo Nordisk's Wegovy® pill (oral semaglutide 25 mg, once daily) has just been by the US as the first GLP‑1 receptor agonist for long‑term weight management and CV risk FDA Approves New Oral GLP-1

JACC Basic Transl Sci 2016;1:267-76.PubMedPMC 25

Peripherally administrated GLP-1RAs may access the brain via ME and AP, as well as other selective CVOs

A multicounty litigation (MCL) has been established in New Jersey, with a new vision loss MDL placed before Judge Marston in federal court

Patients should receive individualized guidance from their healthcare provider regarding injection site selection based on their body composition, comfort level, and ability to properly perform the injection technique

GLP-1 drugs are not antidepressants

This approach minimizes the impact of natural daily weight fluctuations caused by water retention, meals, or other factors